Literature DB >> 23027447

Sex differences in drug effects: interaction with sex hormones in adult life.

Ilaria Spoletini1, Cristiana Vitale, Walter Malorni, Giuseppe M C Rosano.   

Abstract

In recent years, it has become clear that women and men may differ for drug response. Also, there is an increasing recognition on the role of sex hormones on pharmacokinetics and pharmacodynamics as mechanism accounting for sex differences in drug effects.In women, the phases of menstrual cycle, of reproductive life and fluctuations in the concentrations of sexual steroids on pharmacokinetics and pharmacodynamics must be considered. Furthermore, the use of oral contraceptives or hormonal replacement therapy, the sex hormone-related changes in total body water or in the amount of fat influence the overall effect of drugs.On the contrary, the influence of androgens on drug effects is minimal because of the even plasma levels of these hormones in adult males.Nevertheless, since women have been scarcely included in the early phases of clinical trials, the results obtained in men have been often translated to women and their exact response to drugs is still not well known.The available evidence suggests that sex hormones influence drug absorption, distribution, metabolism, pharmacodynamics, and adverse effects. For instance, many cardiovascular drugs are metabolized by enzymes of the cytochrome P450 mono-oxygenases system, which is more expressed in females than in males, showing sex differences in drug response.Upcoming pharmacological research should aim to further clarify the influence of sex hormones on drug effects and, for this purpose, to increase the number of women enrolled in all phases of clinical trials. An evidence-based pharmacotherapy in women is therefore auspicable for women's health.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23027447     DOI: 10.1007/978-3-642-30726-3_5

Source DB:  PubMed          Journal:  Handb Exp Pharmacol        ISSN: 0171-2004


  17 in total

Review 1.  Sex as a Biological Variable: Who, What, When, Why, and How.

Authors:  Tracy L Bale; C Neill Epperson
Journal:  Neuropsychopharmacology       Date:  2016-09-23       Impact factor: 7.853

Review 2.  Ovarian hormones and obesity.

Authors:  Brigitte Leeners; Nori Geary; Philippe N Tobler; Lori Asarian
Journal:  Hum Reprod Update       Date:  2017-05-01       Impact factor: 15.610

Review 3.  Endocrine treatment of aging transgender people.

Authors:  Louis J Gooren; Guy T'Sjoen
Journal:  Rev Endocr Metab Disord       Date:  2018-09       Impact factor: 6.514

4.  Fuzhuan brick tea affects obesity process by modulating gut microbiota.

Authors:  Zhi-Peng Li; Dong-Hui Xu; Lian-Ping He; Xin-Juan Wang
Journal:  World J Gastrointest Pharmacol Ther       Date:  2022-05-05

Review 5.  Pharmacogenomics, pharmacokinetics and pharmacodynamics: interaction with biological differences between men and women.

Authors:  Flavia Franconi; Ilaria Campesi
Journal:  Br J Pharmacol       Date:  2014-02       Impact factor: 8.739

Review 6.  Microphysiological modeling of the reproductive tract: a fertile endeavor.

Authors:  Sharon L Eddie; J Julie Kim; Teresa K Woodruff; Joanna E Burdette
Journal:  Exp Biol Med (Maywood)       Date:  2014-04-15

Review 7.  Contribution of Biotransformations Carried Out by the Microbiota, Drug-Metabolizing Enzymes, and Transport Proteins to the Biological Activities of Phytochemicals Found in the Diet.

Authors:  Anna Boronat; Jose Rodriguez-Morató; Gabriele Serreli; Montserrat Fitó; Rachel F Tyndale; Monica Deiana; Rafael de la Torre
Journal:  Adv Nutr       Date:  2021-12-01       Impact factor: 11.567

8.  The efficacy and safety of selective H1-antihistamine versus leukotriene receptor antagonist for seasonal allergic rhinitis: a meta-analysis.

Authors:  Yu Xu; Jixiang Zhang; Jun Wang
Journal:  PLoS One       Date:  2014-11-10       Impact factor: 3.240

9.  Taking into account the gender issue in cell death studies.

Authors:  E Ortona; P Matarrese; W Malorni
Journal:  Cell Death Dis       Date:  2014-03-13       Impact factor: 8.469

10.  Gender differences in the adverse events' profile registered in seven observational studies of a wide gender-medicine (MetaGeM) project: the MetaGeM safety analysis.

Authors:  Delia Colombo; Emanuela Zagni; Mihaela Nica; Sara Rizzoli; Alessandra Ori; Gilberto Bellia
Journal:  Drug Des Devel Ther       Date:  2016-09-13       Impact factor: 4.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.